SATB2 and neoplasm: In addition to a high CpG island methylator phenotype, factors such as high microsatellite instability, BRAF/RNF43 mutations, consensus molecular subtypes, and high tumor mutational burden are also correlated with decreased mRNA expression of SATB2 [27].